搜索临床试验以:inoperable, progressive/symptomatic plexiform neurofibromas (PN) without any alternative therapeutic
总计92231个结果
-
SanofiRegeneron Pharmaceuticals完全的神经性皮炎法国, 美国, 阿根廷, 中国, 日本, 大韩民国, 墨西哥, 俄罗斯联邦
-
Regeneron PharmaceuticalsTeva Pharmaceutical Industries, Ltd.终止
-
National Institute of Allergy and Infectious Diseases...Juvenile Diabetes Research Foundation; Immune Tolerance Network (ITN)终止
-
International Extranodal Lymphoma Study Group (IELSG)主动,不招人
-
Blessing Corporate Services, IncTakeda Pharmaceuticals North America, Inc.撤销
-
Iaso Maternity Hospital, Athens, Greece完全的
-
Iuliu Hatieganu University of Medicine and PharmacyRomanian Governmental Funding (UEFISCDI)未知
-
Fondazione Italiana Linfomi - ETS主动,不招人
-
Babes-Bolyai University完全的
-
University of MinnesotaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)主动,不招人
-
Genzyme, a Sanofi Company完全的
-
AstraZenecaISTITUTO REGINA ELENA - CENTRO RICERCHE SPERIMENTALI终止
-
Gruppo Oncologico Italiano di Ricerca Clinica招聘中
-
University of California, San Francisco完全的
-
Southwest Oncology GroupNational Cancer Institute (NCI)完全的
-
International Extranodal Lymphoma Study Group (IELSG)招聘中
-
MedeonBio, Inc.主动,不招人
-
Fondazione Italiana Linfomi ONLUS完全的
-
Bayer主动,不招人
-
Novartis Pharmaceuticals终止非小细胞肺癌西班牙, 新加坡, 德国, 瑞士, 澳大利亚, 法国, 意大利, 美国
-
International Extranodal Lymphoma Study Group (IELSG)招聘中
-
Fondazione Italiana Linfomi - ETS主动,不招人外周 T 细胞淋巴瘤 (PTCL) | PTCL-NOS | 血管免疫母细胞性 T 细胞淋巴瘤 (AITL) | ALK- 间变性大细胞淋巴瘤 (ALCL) | T 滤泡辅助细胞来源的淋巴结外周 T 细胞淋巴瘤意大利